First Time Loading...

Yunnan Baiyao Group Co Ltd
SZSE:000538

Watchlist Manager
Yunnan Baiyao Group Co Ltd Logo
Yunnan Baiyao Group Co Ltd
SZSE:000538
Watchlist
Price: 57.25 CNY 2.23% Market Closed
Updated: May 3, 2024

Relative Value

The Relative Value of one Yunnan Baiyao Group Co Ltd stock under the Base Case scenario is 69.1 CNY. Compared to the current market price of 57.25 CNY, Yunnan Baiyao Group Co Ltd is Undervalued by 17%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
69.1 CNY
Undervaluation 17%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
39
vs Industry
45
Median 3Y
2.6
Median 5Y
2.6
Industry
2.4
Forward
2.4
vs History
34
vs Industry
21
Median 3Y
27.9
Median 5Y
22
Industry
22.9
Forward
22.1
vs History
31
vs Industry
16
Median 3Y
24.7
Median 5Y
24.7
Industry
17.1
vs History
9
vs Industry
16
Median 3Y
30.2
Median 5Y
25.4
Industry
23.2
vs History
26
vs Industry
32
Median 3Y
2.5
Median 5Y
2.4
Industry
2.1
vs History
38
vs Industry
49
Median 3Y
2.3
Median 5Y
2.2
Industry
2.6
Forward
2.1
vs History
41
vs Industry
25
Median 3Y
8.7
Median 5Y
8.4
Industry
5.1
vs History
19
vs Industry
15
Median 3Y
22
Median 5Y
20.4
Industry
13.6
Forward
16.3
vs History
19
vs Industry
19
Median 3Y
22
Median 5Y
20.4
Industry
17
Forward
18.3
vs History
25
vs Industry
19
Median 3Y
20.7
Median 5Y
20.2
Industry
15.8
vs History
20
vs Industry
16
Median 3Y
23.7
Median 5Y
22.9
Industry
17.6
vs History
33
vs Industry
30
Median 3Y
2.6
Median 5Y
2.6
Industry
1.9

Multiples Across Competitors

Competitors Multiples
Yunnan Baiyao Group Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Yunnan Baiyao Group Co Ltd
SZSE:000538
102.1B CNY 2.6 25 24.3 24.3
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
697.9B USD 20.5 133.2 60.2 69.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.8T DKK 16.3 45.2 33 36
US
Johnson & Johnson
NYSE:JNJ
357.8B USD 4.4 8.8 11.8 15.5
US
Merck & Co Inc
NYSE:MRK
323.8B USD 5.3 140.4 33.4 53
UK
AstraZeneca PLC
LSE:AZN
186.8B GBP 5.1 39.3 140.6 225.6
CH
Novartis AG
SIX:NOVN
179.8B CHF 4.2 13.3 9.7 16.1
CH
Roche Holding AG
SIX:ROG
172.7B CHF 2.9 15 8.6 10.2
US
Pfizer Inc
NYSE:PFE
155.7B USD 2.7 73.5 11 16.2

See Also

Discover More